Garcia-Fuentes M, Alonso MJ: Chitosan-based drug nanocarriers: wh

Garcia-Fuentes M, Alonso MJ: Chitosan-based drug nanocarriers: where do we stand? J Control Release 2012, 161:496–504.CrossRef 3. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM: Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004, 100:5–28.CrossRef 4. Amidi M, Mastrobattista

E, MRT67307 supplier Jiskoot W, Hennink WE: Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Delivery Rev 2010, 62:59–82.CrossRef 5. Mao S, Sun W, Kissel T: Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Delivery Rev 2010, 62:12–27.CrossRef 6. Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC, Lippard SJ: αVβ3 integrin-targeted PLGA-PEG nanoparticles LY2603618 molecular weight for enhanced anti-tumor

efficacy of a Pt(IV) prodrug. ACS Nano 2012, 6:4530–4539.CrossRef 7. O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL: Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004, 209:171–176.CrossRef 8. Cui F, Li Y, Zhou S, Jia M, Yang X, Yu F, Ye S, Hou Z, Xie L: A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticles. Nanoscale Res Lett 2013, 8:301.CrossRef 9. Allen TM: Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002, 2:750–763.CrossRef 10. Low PS, Henne WA, Doorneweerd DD: Discovery and development of folic-acid-based receptor targeting for imaging and therapy AZD0156 cell line of cancer and inflammatory diseases. Acc Chem Res 2008, 41:120–129.CrossRef 11. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr, Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992, 52:3396–3401. 12. Hou Z, Zhan C, Jiang Q, Hu Q, Li L, Chang D, Yang X, Wang Y, Li Y, Ye S, Xie L, Yi Y, Zhang Q: Both FA- and mPEG-conjugated Leukotriene-A4 hydrolase chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution. Nanoscale Res Lett 2011, 6:563.CrossRef 13. Rijnboutt S, Jansen G, Posthuma G, Hynes JB, Schornagel

JH, Strous GJ: Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol 1996, 132:35–47.CrossRef 14. Mizusawa K, Takaoka Y, Hamachi I: Specific cell surface protein imaging by extended self-assembling fluorescent turn-on nanoprobes. J Am Chem Soc 2012, 134:13386–13395.CrossRef 15. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID: Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006, 127:917–928.CrossRef 16. Frei E, Jaffe N, Tattersall MHN, Pitman S, Parker L: New approaches to cancer chemotherapy with methotrexate. N Engl J Med 1975, 292:846–851.CrossRef 17. Matthews DA, Alden RA, Bolin JT, Freer ST, Hamlin R, Xuong N, Kraut J, Poe M, Williams M, Hoogsteen K: Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science 1977, 197:452–455.CrossRef 18.

Comments are closed.